- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imation purchase boosts Kodak’s sales
Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998’s $442 million, which Kodak attributed to its 1998 acquisition
Eastman Kodak reported increases in fourth quarter and year-end (end-December) revenue for its Health Imaging group. For the quarter, sales were $571 million, up 29% compared with 1998s $442 million, which Kodak attributed to its 1998 acquisition of Imations medical imaging business in a deal worth $520 million (SCAN 8/19/98). For the year, revenues climbed 39% to $2.1 billion from the previous years $1.5 billion.
The Rochester, NY-companys Health Imaging Group also saw dramatic increases in earnings from operations, which rose 232% for the quarter from $38 million in 1998 to $126 million. For the year, the group posted operating earnings of $470 million, up 46% from 1998s $321 million.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
